Saudi Arabia Pharmaceutical CRO Market Size: Forecast (2026-2032)

Saudi Arabia Pharmaceutical CRO Market Report Growth, Trends & Outlook - By Service Type, (Clinical Research Services, Preclinical Research Services, Data Management & Biostatistics, Regulatory Servic... ... s, Regulatory Services, Pharmacovigilance & Safety, Medical Writing & Scientific Communication, Laboratory/Bioanalytical Testing, Site Management & Monitoring, Consulting & Quality Management, Others), By Therapeutic Area, (Oncology, Cardiovascular, Infectious Disease, Neurology, Immunology, Metabolic Disorders, Gastroenterology, Respiratory, Rare & Genetic Diseases, Others) By End User, (Biotech Firms, Medical Device Manufacturers, Academic & Research Institutes, Government & Public Healthcare Agencies), By Contract Type, (Full-Service CROs, Niche/Functional CROs, Hybrid Models), By Phase of Development, (Discovery & Preclinical, Early Phase (I-II), Late Phase (III-IV), Post-Approval & Market Surveillance) Read more

  • Healthcare
  • Oct 2025
  • 162
  • PDF, Excel, PPT

The Saudi Arabia Pharmaceutical CRO Market size is valued at around USD 223 million in 2025 and is projected to reach USD 448 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 14.97% during the forecast period, i.e., 2026-32.

Saudi Arabia Pharmaceutical CRO Market Key Takeaways:

  • According to SFDA procedural regulations, sponsors and CROs are required to register studies in the Saudi Clinical Study Registry and inform the SFDA within certain timeframes (for many study types, this is 20 working days following local IRB clearance). This tightens procedural timelines while lowering "start-up uncertainty."
  • A recurrent requirement in SFDA clinical trial rules is that applicants (and frequently CROs working for foreign sponsors) have an official presence or a legal agent inside the Kingdom.

Saudi Arabia Pharmaceutical CRO Market  Key Trends & Developments:

  • October 09, 2025

King Faisal Specialist Hospital & Research Center (KFSHRC) launched more than 80 new studies in the areas of cancer, cardiology, and metabolic illnesses in the first half of 2025, accounting for over 48% of Saudi Arabia's clinical trials. By administering a locally produced CAR-T cell treatment to its first patient, it also accomplished a significant milestone.

  • June 18, 2025

Saudi Arabia is building its first fully integrated modular Advanced Therapy Medicinal Products (ATMP) manufacturing complex in Riyadh through King Faisal Specialist Hospital & Research Center (KFSHRC) and Germfree Laboratories. The center will boost clinical research capabilities, draw international biotech partnerships, and speed up local cell and gene therapy production.

Saudi Arabia Pharmaceutical CRO Market Scope:

 Category  Segments
By Service Type Clinical Research Services, Preclinical Research Services, Data Management & Biostatistics, Regulatory Services, Pharmacovigilance & Safety, Medical Writing & Scientific Communication, Laboratory/Bioanalytical Testing, Site Management & Monitoring, Consulting & Quality Management, Others
By Therapeutic Area Oncology, Cardiovascular, Infectious Disease, Neurology, Immunology, Metabolic Disorders, Gastroenterology, Respiratory, Rare & Genetic Diseases, Others
By End User Biotech Firms, Medical Device Manufacturers, Academic & Research Institutes, Government & Public Healthcare Agencies
By Contract Type Full-Service CROs, Niche/Functional CROs, Hybrid Models
By Phase of Development Discovery & Preclinical, Early Phase (I-II), Late Phase (III-IV), Post-Approval & Market Surveillance

  1. Market Segmentation
  2. Introduction
    2.1. Product Definition
    2.2. Research Process
    2.3. Assumptions
  3. Executive Summary
  4. Saudi Arabia Pharmaceutical CRO Market Policies, Regulations, and Product Standards
  5. Saudi Arabia Pharmaceutical CRO Market Supply Chain Analysis
  6. Saudi Arabia Pharmaceutical CRO Market Trends & Developments
  7. Saudi Arabia Pharmaceutical CRO Market Dynamics
    1. Growth Drivers
    2. Challenges
  8. Saudi Arabia Pharmaceutical CRO Market Hotspot & Opportunities
  9. Saudi Arabia Pharmaceutical CRO Market Outlook, 2020-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Million Units or Projects)
    2.  Market Share & Outlook
      1.  By Service Type– Market Size & Forecast 2020-2032, USD Million & Million Projects
        1. Clinical Research Services – Market Size & Forecast 2020-2032, USD Million & Million Projects
          1. Phase I– Market Size & Forecast 2020-2032, USD Million & Million Projects
          2. Phase II– Market Size & Forecast 2020-2032, USD Million & Million Projects
          3. Phase III– Market Size & Forecast 2020-2032, USD Million & Million Projects
          4. Phase IV– Market Size & Forecast 2020-2032, USD Million & Million Projects
             
        2. Preclinical Research Services– Market Size & Forecast 2020-2032, USD Million & Million Projects
        3. Data Management & Biostatistics– Market Size & Forecast 2020-2032, USD Million & Million Projects
        4. Regulatory Services – Market Size & Forecast 2020-2032, USD Million & Million Projects
        5. Pharmacovigilance & Safety– Market Size & Forecast 2020-2032, USD Million & Million Projects
        6. Medical Writing & Scientific Communication– Market Size & Forecast 2020-2032, USD Million & Million Projects
        7. Laboratory/Bioanalytical Testing– Market Size & Forecast 2020-2032, USD Million & Million Projects
        8. Site Management & Monitoring– Market Size & Forecast 2020-2032, USD Million & Million Projects
        9. Consulting & Quality Management– Market Size & Forecast 2020-2032, USD Million & Million Projects
        10. Others
      2. By Therapeutic Area– Market Size & Forecast 2020-2032, USD Million & Million Projects
        1. Oncology– Market Size & Forecast 2020-2032, USD Million & Million Projects
        2. Cardiovascular– Market Size & Forecast 2020-2032, USD Million & Million Projects
        3. Infectious Disease– Market Size & Forecast 2020-2032, USD Million & Million Projects
        4. Neurology– Market Size & Forecast 2020-2032, USD Million & Million Projects
        5. Immunology– Market Size & Forecast 2020-2032, USD Million & Million Projects
        6. Metabolic Disorders– Market Size & Forecast 2020-2032, USD Million & Million Projects
        7. Gastroenterology– Market Size & Forecast 2020-2032, USD Million & Million Projects
        8. Respiratory– Market Size & Forecast 2020-2032, USD Million & Million Projects
        9. Rare & Genetic Diseases– Market Size & Forecast 2020-2032, USD Million & Million Projects
        10. Others
      3. By End User– Market Size & Forecast 2020-2032, USD Million & Million Projects
        1. Biotech Firms– Market Size & Forecast 2020-2032, USD Million & Million Projects
        2. Medical Device Manufacturers– Market Size & Forecast 2020-2032, USD Million & Million Projects
        3. Academic & Research Institutes– Market Size & Forecast 2020-2032, USD Million & Million Projects
        4. Government & Public Healthcare Agencies– Market Size & Forecast 2020-2032, USD Million & Million Projects
      4. By Contract Type– Market Size & Forecast 2020-2032, USD Million & Million Projects
        1. Full-Service CROs– Market Size & Forecast 2020-2032, USD Million & Million Projects
        2. Niche/Functional CROs– Market Size & Forecast 2020-2032, USD Million & Million Projects
        3. Hybrid Models– Market Size & Forecast 2020-2032, USD Million & Million Projects
      5. By Phase of Development– Market Size & Forecast 2020-2032, USD Million & Million Projects
        1. Discovery & Preclinical– Market Size & Forecast 2020-2032, USD Million & Million Projects
        2. Early Phase (I-II) – Market Size & Forecast 2020-2032, USD Million & Million Projects
        3. Late Phase (III-IV) – Market Size & Forecast 2020-2032, USD Million & Million Projects
        4. Post-Approval & Market Surveillance– Market Size & Forecast 2020-2032, USD Million & Million Projects
      6.  By Region
        1. Riyadh (Central Region)
        2. Jeddah (Western Region)
        3. Dammam & Khobar (Eastern Region)
        4. Medina (Northwestern Region)
        5. Others (Southern & Peripheral Areas)
      7. By Company
        1.  Company Revenue Shares
        2. Competitor Characteristics
  10. Saudi Arabia Clinical Research Services Market Outlook, 2020-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Number of Trials or Projects)
    2. Market Share & Outlook
      1. By Phase – Market Size & Forecast 2020-2032, USD Million & Million Projects
      2. By Therapeutic Area– Market Size & Forecast 2020-2032, USD Million & Million Projects
      3. By End-User– Market Size & Forecast 2020-2032, USD Million & Million Projects
      4. By Region
  11. Saudi Arabia Preclinical & Laboratory Services Market Outlook, 2020-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Volume (Number of Studies)
    2. Market Share & Outlook
      1. By Type– Market Size & Forecast 2020-2032, USD Million & Million Projects
      2. By End-User– Market Size & Forecast 2020-2032, USD Million & Million Projects
      3. By Region
  12. Saudi Arabia Data Management & Regulatory Services Market Outlook, 2020-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
      2. By Number of Projects/Clients
    2. Market Share & Outlook
      1. By Service Type– Market Size & Forecast 2020-2032, USD Million & Million Projects
      2. By End-User– Market Size & Forecast 2020-2032, USD Million & Million Projects
      3. By Region
  13. Saudi Arabia Pharmaceutical CRO Market Key Strategic Imperatives for Success & Growth
  14. Competition Outlook
    1. Company Profiles
      1. ArabMed CRO (Saudi Arabia)
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Balsam Clinical Research (Saudi Arabia)
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Mesned CRO (Saudi Arabia)
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Clinart MENA
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. King Faisal Specialist Hospital & Research Centre (KFSHRC) Clinical Trials Unit
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Quintiles IMS (IQVIA)
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. ICON plc
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. SGS Life Sciences
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. WuXi AppTec
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Thermo Fisher Scientific
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. LabCorp Drug Development
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Syneos Health
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Medpace
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Covance
        1. Business Description
        2. Service Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Others
  15. Disclaimer

 


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .